Birchview Capital, LP Chemo Centryx, Inc. Transaction History

Birchview Capital, LP

  • $108 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$18.38 - $40.5 $91,900 - $202,500
-5,000 Reduced 20.0%
20,000 $728,000
Q3 2021

Nov 12, 2021
SELL
$13.18 - $19.83 $65,900 - $99,149
-5,000 Reduced 16.67%
25,000 $428,000
Q1 2020

May 12, 2020
BUY
$32.73 - $50.78 $163,649 - $253,900
5,000 Added 20.0%
30,000 $1.21 Million
Q4 2019

Feb 12, 2020
BUY
$6.81 - $39.55 $170,250 - $988,749
25,000 New
25,000 $989,000

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Birchview Capital, LP Portfolio

Follow Birchview Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Birchview Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email